Introduction to antibody engineering and phage display
- PMID: 10765141
- DOI: 10.1159/000031154
Introduction to antibody engineering and phage display
Abstract
The vertebrate immune system, capable of rapidly producing highly specific antibodies upon immunisation, has been used to produce murine monoclonal antibodies (mAbs) via immortalisation and isolation of antibody-secreting cells. These mAbs have had a profound impact in the fields of diagnostics and therapeutics. However, the therapeutic use of murine mAbs is complicated by their immunogenicity. To circumvent this immunogenicity, antibody engineering techniques which render murine mAbs more compatible with the human immune system have been devised. Over the last decade, the technique of antibody phage display, which facilitates the production of human mAbs, has been developed. This review serves as an introduction to antibody engineering, phage display and the development of antibody fragments into viable diagnostic and therapeutic reagents.
Similar articles
-
Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.Biochem Biophys Res Commun. 2004 Oct 15;323(2):583-91. doi: 10.1016/j.bbrc.2004.08.131. Biochem Biophys Res Commun. 2004. PMID: 15369791
-
[Progress on phage antibody library technology].Wei Sheng Yan Jiu. 2004 Nov;33(6):765-8. Wei Sheng Yan Jiu. 2004. PMID: 15727199 Review. Chinese.
-
Phage libraries for generation of anti-botulinum scFv antibodies.Methods Mol Biol. 2000;145:219-40. doi: 10.1385/1-59259-052-7:219. Methods Mol Biol. 2000. PMID: 10820725 No abstract available.
-
Construction of polyclonal antibody libraries using phage display.Methods Mol Biol. 2002;178:101-12. doi: 10.1385/1-59259-240-6:101. Methods Mol Biol. 2002. PMID: 11968479 Review. No abstract available.
-
Construction of phage antibody repertoires from the blood of West Nile virus-infected donors.Methods Mol Biol. 2009;562:45-60. doi: 10.1007/978-1-60327-302-2_4. Methods Mol Biol. 2009. PMID: 19554286
Cited by
-
Expression and bioactivity identification of soluble MG7 scFv.World J Gastroenterol. 2002 Feb;8(1):99-102. doi: 10.3748/wjg.v8.i1.99. World J Gastroenterol. 2002. PMID: 11833081 Free PMC article.
-
Antibody-Based Protective Immunity against Helminth Infections: Antibody Phage Display Derived Antibodies against BmR1 Antigen.Int J Mol Sci. 2017 Nov 22;18(11):2376. doi: 10.3390/ijms18112376. Int J Mol Sci. 2017. PMID: 29165352 Free PMC article.
-
Therapeutic applications of monoclonal antibodies.Am J Med Sci. 2002 Jul;324(1):14-30. doi: 10.1097/00000441-200207000-00004. Am J Med Sci. 2002. PMID: 12120821 Free PMC article. Review.
-
Development of a Monoclonal scFv against Cytotoxin to Neutralize Cytolytic Activity Induced by Naja atra Venom on Myoblast C2C12 Cells.Toxins (Basel). 2022 Jul 4;14(7):459. doi: 10.3390/toxins14070459. Toxins (Basel). 2022. PMID: 35878197 Free PMC article.
-
scFv antibody: principles and clinical application.Clin Dev Immunol. 2012;2012:980250. doi: 10.1155/2012/980250. Epub 2012 Mar 15. Clin Dev Immunol. 2012. PMID: 22474489 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources